A jury in the Eastern District of Texas returned a verdict of $1.67 billion yesterday, in what some have described as the largest patent-infringement verdict in U.S. history. Abbott's product, Humira, was found to infringe Patent No. 7,070,775. Centocor's competing arthritis drug is Remicade. The jury determined that the '775 patent was infringed and not invalid, and awarded $1,168,466,000 in lost profits and $504,128,000 in reasonable royalty damages.
Centocor, Inc. et al v. Abbott Laboratories, 2-07-cv-00139
(TXED June 29, 2009, Verdict)